Rita Dundon
Adult Medicine · Plymouth Meeting, PANPI 1770145963
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 40.8% of the total. 2024 is the largest year on record at $570, 8.0 times the $71 reported in 2022.
Across 74 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$468
- Bausch Health US, LLC$108
- Pfizer$97
- AstraZeneca$86
- Lilly USA, LLC$77
- Idorsia Pharmaceuticals US Inc$74
- plus $236 from 9 others
What the payments were for
- Food & beverage$1,146100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $468 |
| Bausch Health US, LLC | 5 | $108 |
| Pfizer | 5 | $97 |
| AstraZeneca | 5 | $86 |
| Lilly USA, LLC | 4 | $77 |
| Idorsia Pharmaceuticals US Inc | 4 | $74 |
| Astellas Pharma US Inc | 2 | $57 |
| Novo Nordisk | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Exact Sciences | 1 | $28 |
| Dynavax Technologies Corporation | 1 | $21 |
| GSK | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$1,146 in reported general payments places this provider in the 75th percentile of 52 adult medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 24 | $22,486 |
| Fluoxetine Hcl | 14 | $2,938 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,286 |
| SynthroidLevothyroxine Sodium | 13 | $1,071 |
| Rosuvastatin Calcium | 39 | $1,044 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $796 |
| Gabapentin | 34 | $774 |
| Omeprazole | 33 | $640 |
| Levothyroxine Sodium | 51 | $603 |
| Lisinopril | 54 | $550 |
| Atorvastatin Calcium | 53 | $523 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 22 | $479 |
| Fluticasone Propionate | 39 | $404 |
| Metoprolol Succinate | 25 | $397 |
| Hydrochlorothiazide | 39 | $395 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $34 | $22,48624 claims |
| AbbVieSynthroid | $468 | $1,07113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 52 adult medicine providers in Pennsylvania.
Other adult medicine in Plymouth Meeting
- Peter HonigPhiladelphia$140K
- Mark WatkinsPhiladelphia$54K
- Emily ScaruzziPhiladelphia$16K
- Harvey SpectorPhiladelphia$15K
- Gina SloboginUpper Chichester$15K
- Larry HahnTrevose$8K
- Gregory GeorgeSharon$7K
- Victoria KorkusPhoenixville$4K
- Jay RobinsonCoalport$3K
- Matthew KulkaLanghorne$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.